Menopause Flashcards Preview

Obstetrics and Gynaecology > Menopause > Flashcards

Flashcards in Menopause Deck (23)
Loading flashcards...
1
Q

Define normal, early

A

Cessation of menses for >12 months

Early is when <40 yo

2
Q

Average age of onset

A

Usually 45-55, average age is 50-51

3
Q

The four phases

A
  1. Phase 1 Premenopausal: up to 5 years before the last menstrual period.
  2. Phase 2 Perimenopausal: the presence of early menopausal symptoms with vaginal bleeding (usually irregular) 3. Phase

3 Menopausal: the last menstrual period

  1. Phase 4 Postmenopausal: approximately 5 years after the menopause
4
Q

During menopause, does the ovary produce must estrogen or androgens

A
  1. The ovary produces little estrogen 2. Produces ++androgens
5
Q

Symptoms overview

A
  1. Vasomotor
  2. Psychogenic
  3. Urogenital
  4. MSK
  5. Skin and other tissue changes
  6. Other
6
Q

Vasomotor symptoms

A
  1. Hot flushes
  2. Night sweats
  3. Palpitations
  4. Lightheadedness
  5. Migraine
7
Q

Psychogenic symptoms

A
  1. Depression
  2. Irritability
  3. Mood swings
  4. Anxiety
  5. Tearfullness
  6. Poor concentration
  7. Sleep disturbance
  8. Loss of self confendence
8
Q

Urogenital symptoms

A
  1. Atrophic vaginitis
  2. Vaginal dryness
  3. Dysparaneuria
  4. Decline in libido
  5. Bladder dusfunction
  6. Stress incontinence
9
Q

Musckuloskeletal symptoms

A
  1. Non-specific muscular aches
  2. Non-specific joint aches and pains
10
Q

Skin and other tissue symptoms

A
  1. Dry skin
  2. Fornicatioin
  3. New facial hair
  4. Breast glandular atrophy
11
Q

Other symptoms

A
  1. Unusual tiredness
  2. Headache
12
Q

History

A
  1. Symptoms of estrogen deficiency
  2. Gynaecological history
  3. Obstetric history
  4. Mental state symptoms
  5. Sexual history
  6. Contraception
  7. Micturition
  8. Social history
  9. Family history of osteoporosis, cancer, cardiovascular disease
13
Q

Examination

A
  1. BP, height, weight, waist
  2. Breast
  3. Abdomen
  4. Vaginal examination
  5. Pap smear
14
Q

Investigations

A
  1. Urinalysis
  2. FBC
  3. Fasting lipids, glucose
  4. LFTs
  5. Mammography

If in doubt, or early

  1. Serum FSH
  2. Serum estradiol
15
Q

Management

A
  1. Education and lifestyle Diet Obesity Relaxation Exercise Smoking Caffeine and alcohol reduction Pelvic floor
  2. Continue sexual relations->use lubricant
  3. Contraception for 12 months after last period
  4. OCP available until 50/51
  5. Consider HRT->allow 6 months to stabilise
  6. Estrogen pessary for vaginal dryness
  7. Consider non-hormonal: Paroxetine or venlafaxine
  8. Consider short term testosterone if loss of libido issue 9. Regular followup
16
Q

Important aspects of the women’s health initiative study

A
  1. first prospective, randomized, controlled clinical trial of hormone replacement therapy (HRT), it aimed to recruit more than 16,000 women and do follow-up on them for 8.5 years.
  2. A 37% reduction in colon cancer
  3. 34% decrease in hip fractures
  4. 2.11-fold increase in deep venous thromboses
  5. 26% increase in invasive breast cancer This finding was surprising, since a recent comprehensive review of previous epidemiologic studies had concluded that no convincing link between breast cancer and HRT was present.
  6. The big WHI surprises were the 29% increase in heart attacks and the 41% increase in strokes that were seen.
  7. A major problem is that HRT is the only potent therapy for vasomotor symptoms and genital atrophy in menopausal women
  8. In addition to increased adherence to dietary/lifestyle modifications, women concerned with osteoporosis might be better served by taking SERMs (eg, raloxifene hydrochloride) or bisphosphonates (alendronate sodium, risedronate sodium); either seems to give the same approximate fracture prevention as HRT
17
Q

Indications for HRT

A
  1. Relieving distressing symptoms of hot flushed, urogenital symptoms, sleepiness and joint
  2. Transdermal most favoured.
18
Q

Golden rule in HRT

A
  1. Progesterone must be give with estrogen in women who still have a uterus
19
Q

Tibolone

A
  1. SERM
  2. Alternative to traditional HRT
  3. Vasomotor, urogenital, BMD and fracture risk
  4. Not for perimenopausal
  5. Breakthrough bleeding and virilisation are the concerns
20
Q

Contraindications to HRT

A
  1. Estrogen dependent tumor
  2. Recurrent VTE
  3. Acute IHD
  4. CAD
  5. Cerebrovascular
  6. Uncontrolled HTN
  7. Undiagnosed vaginal bleeding
  8. Acute liver disease
  9. Active SLE
  10. Pregnancy
  11. Osteosclerosis
  12. Acute intermittent porphyria
21
Q

Complications

A
  1. Uterine enlargment->irregular bleeding
  2. Continued periods
  3. Maignancy? No increase in cervical or ovarian cancer Risk of endometrial Ca->relates to unopposed estrogen and duration of use: 3-6X risk after 5 years, 10X risk after 10 years. Breast cancer
  4. VTE
  5. MI
  6. Stroke
  7. Cholecystitis and cholelithiasis
22
Q

Side effects

A
  1. Generally well tolerated
  2. May have some breast tenderness, HA, breast fullness, often resolves after 3 months.
23
Q

Components of WHI to explain: end point, criticisms, conclusion

A
  1. Were older, had other risks, cannot extrapolate to younger, healthy women early in menopause wanting symptom releif
  2. End point- Breast Ca

Secondary end-points +Myocardial infarction +Cerebrovascular accidents +Pulmonary thrombosis

  • ve Fracture of the hip
  • ve Cancer of the colon

?Endometrial carcinoma

Stopped early as incidence of breast carcinoma increased, not mortality

  1. Concluded not suitable for primary prevention->relative risk of adverse effects +15% however, absolute risks not great.